Representation of the Body for Patients With Cancer

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

21 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-11-30

Study Completion Date

2013-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The project aims to understand better how patients live the event of cancer and live its consequences on their bodily representations. In the study, the dynamic of the body image is not restricted to appearance but include sensations and visions of the inner body, what explains the choice of peritoneal cancer, and the treatment by cytoreductive surgery and HIPEC.

The three objectives of the study are:

* identifying the impact of the representations of the treated body on the psychological strategies to cope with the disease, the bodily changes and the prospects of life;
* making explicit the positive or negative impacts of these representations on the relationship between patients and health professionals (easing factors, misunderstandings, negotiations, etc.);
* associating the health professionals with the study in its course and evaluation in order to elaborate a methodological collaborative approach between patients, health professionals and researchers in social sciences.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Impact of a Psychoeducational Intervention on Expectations and Coping in Young Women Exposed to a High HBOC Risk

NCT02705924

Hereditary Breast and Ovarian Cancer Syndrome

TERMINATED NA

Personal Resilience Empowerment Program Study

NCT03644173

Lung Cancer Cholangiocarcinoma Pancreatic Cancer +1 more

COMPLETED NA

JUMP Prevalence of Sarcopenia and Chemobrain in Post-cancer Patients

NCT05800535

Cancer Sarcopenia

RECRUITING

Perception Prognosis, Goals of Treatment, and Communication

NCT01401894

Gastric Cancer Esophageal Cancer Pancreatic Cancer +2 more

COMPLETED

Identify the Obstacles to Early Diagnosis of Cancer in Patients Over 75 Years Old, on an Outpatient Basis

NCT04395040

Cancer Aging

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Peritoneal Carcinomatosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Treated by HIPEC

Patients treated by HIPEC for peritoneal cancer

Group Type OTHER

Interviews

Intervention Type BEHAVIORAL

Interviews will be done with patients

Standard chemiotherapy

Patients treated by standard chemiotherapy for peritoneal cancer

Group Type OTHER

Interviews

Intervention Type BEHAVIORAL

Interviews will be done with patients

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Interviews

Interviews will be done with patients

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients eligible to treatment of cancer by cytoreductive surgery and HIPEC
* Primary (pseudomyxoma, mesothelioma) and secondary (colorectal, gastric, ovarian) peritoneal cancer
* Free consent
* Male or Female
* Age \> 18 years
* Affiliate to social security